Professor of Medicine, Professor of Molecular Microbiology and Immunology
Brown University
Disclosure(s): Chemic Labs/KODA Therapeutics: Grant/Research Support; Cidara: Grant/Research Support; Leidos Biomedical Research Inc./NCI: Grant/Research Support; NIH/NIAID, NIH/NIGMS: Grant/Research Support; Pfizer: Grant/Research Support; Regeneron Pharmaceuticals, Inc.: Grant/Research Support; SciClone Pharmaceuticals: Grant/Research Support
Dr. Eleftherios Mylonakis, Charles C.J. Carpenter Professor of Infectious Disease at Brown University, is also the Chief of Infectious Diseases at Rhode Island Hospital and the Miriam Hospital and Director of the COBRE Center for Antimicrobial Resistance and Therapeutic Discovery. He is Assistant Dean for Outpatient Investigations and Director of the Center for Outpatient and Longitudinal Medical Research at the Alpert Medical School of Brown University and Professor of Molecular Microbiology and Immunology. He was previously Attending Physician of Infectious Disease at Massachusetts General Hospital and served as an Associate Professor at Harvard Medical School. Dr. Mylonakis studies host and microbial factors of infection and the discovery of antimicrobial agents. His research encompasses both clinical and laboratory studies and the use of mammalian and invertebrate model hosts systems to identify novel antimicrobial compounds and the elucidation of evolutionarily conserved aspects of microbial virulence and the host response. He has 8 patents, edited five books and almost 400 articles in the peer-reviewed literature.